Medicine & Life Sciences
Breast Neoplasms
84%
Interferon Regulatory Factor-1
53%
polyphenon E
45%
Neoplasms
34%
gemcitabine
30%
Genes
28%
Estrogen Receptor alpha
27%
Phosphatidylinositol 3-Kinase
25%
Tea
25%
human XBP1 protein
24%
PIK 75
24%
Hormones
23%
Mutation
23%
diacetyldiphenylurea bisguanylhydrazone
22%
Gene Expression
21%
Biomarkers
21%
DNA Damage
20%
Cell Line
20%
Breast
20%
Phosphatidylinositol 3-Kinases
19%
Parkinson Disease
19%
Checkpoint Kinase 2
19%
Carcinogenesis
19%
Hepatocellular Carcinoma
18%
Progesterone Receptors
18%
Isothiocyanates
18%
Post-Traumatic Epilepsy
18%
glutathione S-transferase M1
18%
glutathione S-transferase T1
18%
MicroRNAs
17%
Data Analysis
17%
nucleophosmin
17%
Loss of Heterozygosity
17%
Pancreatic Neoplasms
16%
Adenosquamous Carcinoma
16%
Suppressor Genes
16%
Circulating MicroRNA
16%
15-hydroxyprostaglandin dehydrogenase
16%
Genome
15%
Neoplasm Genes
15%
Microarray Analysis
15%
Triamcinolone
15%
Essential Thrombocythemia
15%
Levetiracetam
15%
Thymidylate Synthase
15%
Keloid
15%
Epithelial Cells
15%
Proteins
15%
Squamous Cell Carcinoma
15%
bisphenol A
15%
Mathematics
Copula Models
100%
Archimedean Copula
99%
Frailty Model
44%
Censored Data
26%
Action Recognition
23%
Truncated Data
23%
Goodness of Fit Test
23%
Texture Feature
22%
Dependent Data
22%
Remote Sensing Image
22%
Content Analysis
21%
Gene Selection
19%
Image Classification
19%
Estimator
18%
Microarray Data Analysis
18%
Survival Function
17%
Cure Model
17%
Association Measure
17%
Dependent Censoring
16%
Classification Algorithm
16%
Strategy
16%
Competing Risks Model
16%
Measures of Association
15%
Identifiability
15%
Marginal Function
15%
Failure Time Data
15%
Correlated Data
15%
Dependent
14%
Model
14%
Right-censored Data
14%
Censoring
13%
Hazard Function
13%
Data Model
13%
Baseline
12%
Leukemia
12%
Virus
12%
Principal Component Analysis
12%
Mixture Model
12%
Gene
11%
Model Checking
11%
Human
10%
Specification
10%
Likelihood
10%
Simulation Study
9%
Failure Time
8%
Summarization
8%
Multivariate Data Analysis
8%
Language
8%
